46. Malignant rheumatoid arthritis Clinical trials / Disease details


Clinical trials : 4,325 Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01712178
(ClinicalTrials.gov)
June 201214/6/2012A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and SafetyStudy to Assess the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of a New Adalimumab Formulation in Subjects With Active Rheumatoid ArthritisRheumatoid ArthritisBiological: Adalimumab, current formulation;Biological: Adalimumab, new formulationAbbVie (prior sponsor, Abbott)NULLCompleted18 YearsN/AAll100Phase 2United States;Belgium;Czech Republic;Germany;Puerto Rico;Romania;Slovakia